World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
14803
World Ranking
2721
National Ranking
1094

Thomas L. Richie publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Thomas L. Richie sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 192 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Thomas L. Richie D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas L. Richie sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Thomas L. Richie is affiliated with the Naval Medical Research Center in the United States. Their research portfolio focuses primarily on medicine, with significant contributions to public health, environmental and occupational health, molecular biology, immunology, parasitology, and infectious diseases. The overarching themes of their work revolve around malaria research and control, mosquito-borne diseases, vaccines and immunoinformatics approaches, travel-related health issues, parasites and host interactions, the complement system in diseases, and vector-borne infectious diseases.

Richie has published extensively on malaria and infectious diseases, with notable recent papers including:

  • Ethics of controlled human infection to address COVID-19, 2020, Science
  • Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity, 2021, Nature
  • Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial, 2021, Nature Medicine
  • A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1, 2020, Science Translational Medicine
  • Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial, 2021, The Lancet Infectious Diseases

Their frequent co-authors include Stephen L. Hoffman, B. Kim Lee Sim, Peter F. Billingsley, Tooba Murshedkar, and Eric R. James. These collaborators have appeared in numerous publications alongside Richie, indicating a collaborative research environment centered on malaria vaccine development and infectious disease control.

Richie's work has appeared in several recurring publication venues, such as:

  • American Journal of Tropical Medicine and Hygiene
  • The Lancet Infectious Diseases
  • PLoS ONE
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science Translational Medicine

The scientific topics addressed in Richie's research emphasize the control and understanding of mosquito-borne diseases and malaria. A focus on vaccines is evident, alongside investigations into host-parasite interactions and immunological responses relevant to infectious diseases. Their contributions span clinical trials, immunogenicity studies, and ethical considerations in controlled human infection models to address emergent and endemic diseases.

Best Publications

  • Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites

    Stephen L. Hoffman;Lucy M. L. Goh;Thomas C. Luke;Imogene Schneider

  • Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

    Robert A. Seder;Lee Jah Chang;Mary E. Enama;Kathryn L. Zephir

  • Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity

    J. E. Epstein;K. Tewari;K. E. Lyke;B. K. L. Sim

  • Progress and challenges for malaria vaccines.

    Thomas L. Richie;Allan Saul

  • Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

    Benjamin Mordmüller;Güzin Surat;Heimo Lagler;Heimo Lagler;Sumana Chakravarty

  • Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.

    Andrew S Ishizuka;Kirsten E Lyke;Adam DeZure;Andrea A Berry

  • Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.

    Stephen L Hoffman;Peter F Billingsley;Eric James;Adam Richman

  • Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial

    Mahamadou S Sissoko;Sara A Healy;Abdoulaye Katile;Freda Omaswa

  • Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

    Ruobing Wang;Judith Epstein;Fe Maria Baraceros;Edward J. Gorak

  • Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells.

    Rebecca Danner;Snehal N. Chaudhari;John Rosenberger;Jacqueline Surls

  • Protection against Plasmodium falciparum malaria by PfSPZ Vaccine

    Judith E. Epstein;Kristopher M. Paolino;Thomas L. Richie;Martha Sedegah

  • Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

    Kirsten E. Lyke;Andrew S. Ishizuka;Andrea A. Berry;Sumana Chakravarty

  • The RTS,S malaria vaccine

    Sofia Casares;Teodor-Doru Brumeanu;Thomas L. Richie

  • A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

    S. J. Dunachie;M. Walther;J. E. Epstein;S. Keating

  • The March Toward Malaria Vaccines

    Stephen L. Hoffman;Johan Vekemans;Thomas L. Richie;Patrick E. Duffy

  • Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.

    Thomas L. Richie;Peter F. Billingsley;B. Kim Lee Sim;Eric R. James

  • Update on the clinical development of candidate malaria vaccines

    W. Ripley Ballou;Myriam Arevalo-Herrera;Daniel Carucci;Thomas L. Richie

  • Mefloquine Compared with Doxycycline for the Prophylaxis of Malaria in Indonesian Soldiers: A Randomized, Double-Blind, Placebo-Controlled Trial

    C Ohrt;T L Richie;H Widjaja;G D Shanks

  • Sterile Protective Immunity to Malaria is Associated with a Panel of Novel P. falciparum Antigens

    Angela Trieu;Matthew A. Kayala;Chad Burk;Douglas M. Molina

  • Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia.

    Walter R. J. Taylor;Thomas L. Richie;David J. Fryauff;Helena Picarima

Frequent Co-Authors

Martha Sedegah
Martha Sedegah Naval Medical Research Center
Denise L. Doolan
Denise L. Doolan Australian Institute of Tropical Health and Medicine
Marcel Tanner
Marcel Tanner Swiss Tropical and Public Health Institute
Daniel J. Carucci
Daniel J. Carucci Naval Medical Research Center
Robert A. Seder
Robert A. Seder National Institute of Allergy and Infectious Diseases
Benjamin Mordmüller
Benjamin Mordmüller Radboud University Medical Center
Christian F. Ockenhouse
Christian F. Ockenhouse Walter Reed Army Institute of Research
Patrick E. Duffy
Patrick E. Duffy National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to diverse online degree options and career pathways within the healthcare and scientific fields. For those seeking flexible education routes, exploring best associate degrees for felons can provide valuable guidance on accessible programs that accommodate various backgrounds.

One promising career progression is becoming a functional nurse practitioner. This role integrates clinical expertise with holistic wellness approaches, making it a dynamic option for microbiology graduates interested in nursing and patient care.

For those focused on administrative and coding roles within healthcare settings, the path to becoming a certified professional coder (CPC) offers specialized training in medical coding—an essential function for hospital billing and health data management.

Additionally, Microbiology graduates can consider advancing into healthcare management by pursuing careers like a health information manager salary often reflects the responsibility of overseeing vital patient data and ensuring regulatory compliance.

Best Scientists Citing Thomas L. Richie

Trending Scientists

Recently Published Articles